Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Arbutus Biopharma Corporation (ABUS) had Days Sales in Receivables of 60.31 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$1.76M |
|
$-24.53M |
|
-- |
|
$1.76M |
|
$27.46M |
|
$-25.70M |
|
$1.17M |
|
$-24.53M |
|
$-24.53M |
|
$-24.53M |
|
$-24.53M |
|
$-24.53M |
|
$-24.53M |
|
$-25.70M |
|
$-25.37M |
|
190.71M |
|
190.71M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$116.81M |
|
$0.17M |
|
$0.20M |
|
$117.01M |
|
$19.43M |
|
$2.86M |
|
$18.42M |
|
$37.85M |
|
$79.16M |
|
$79.16M |
|
$79.16M |
|
191.48M |
|
| Cash Flow Statement Financials | |
$-13.39M |
|
$11.35M |
|
$2.78M |
|
$36.33M |
|
$37.08M |
|
$0.75M |
|
$3.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.01 |
|
-- |
|
-- |
|
0.03 |
|
0.04 |
|
100.00% |
|
-1456.86% |
|
-1456.86% |
|
-- |
|
-1390.36% |
|
-1390.36% |
|
$-13.39M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
1.49 |
|
|
Days Sales in Receivables |
60.31 |
-30.98% |
|
-30.98% |
|
-20.96% |
|
-29.90% |
|
$0.41 |
|
$-0.07 |
|
$-0.07 |
|